[July 19, 2016]

Global 20s Proteasome Pipeline Report 2016 - Therapeutics Activities of Amgen Inc & LG Life Science - Research and Markets

Research and Markets has announced the addition of the "20s Proteasome - Pipeline Review, H1 2016" drug pipelines to their offering.

20s Proteasome pipeline Target (News - Alert) constitutes close to 8 molecules. Out of which approximately 8 molecules are developed by Companies. Our latest report 20s Proteasome - Pipeline Review, H1 2016, outlays comprehensive information on the 20s Proteasome targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

20s Proteasome 20S proteasome is the catalytic core of the 26S proteasome, the central protease of the ubiquitin pathway of protein degradation. It is commonly associated with regulatory complexes, which include the 19S Proteasome, the PA28 alpha/beta complex, or the PA28 gamma complex. The 20S Proteasome is composed of 28 subunits arranged into four stacked ings. Unlike the 26S proteasome, which degrades proteins in an ATP (News - Alert)-dependent manner, the 20S proteasome is ATP-independent and only degrades entirely unfolded polypeptides. The molecules developed by Companies in Pre-Registration, Phase II, Preclinical and Discovery stages are 1, 2, 3 and 2 respectively.

Furthermore, this report also reviews key players involved in 20s Proteasome targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Key Topics Covered:

1. Introduction
2. 20s Proteasome Overview
3. Therapeutics Development
4. Pipeline Products for 20s Proteasome - Overview
5. Pipeline Products for 20s Proteasome - Comparative Analysis
6. 20s Proteasome - Therapeutics under Development by Companies
7. 20s Proteasome - Therapeutics under Investigation by Universities/Institutes
8. 20s Proteasome Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. 20s Proteasome - Products under Development by Companies
13. 20s Proteasome - Products under Investigation by Universities/Institutes
14. 20s Proteasome - Companies Involved in Therapeutics Development

• Amgen Inc.
• LG Life Science LTD.

For more information visit http://www.researchandmarkets.com/research/xh965f/20s_proteasome

View source version on businesswire.com: http://www.businesswire.com/news/home/20160719006247/en/

[ Back To TMCnet.com's Homepage ]